Related Funds
Fund Name | Location |
Atmos Ventures | California, Palo Alto, United States |
BackingMinds | - |
Bright Stone | Beijing, Beijing, China |
Cheshire & Warrington | England, Somerset West and Taunton, United Kingdom |
CIDCO | California, Morgan Hill, United States |
EIV Capital | Houston, Texas, United States |
Level One Partners | - |
Leyu Tianqi Culture Communication | - |
LGB & Co | England, London, United Kingdom |
Maxygen | California, Redwood City, United States |
Metellus | Switzerland, Zurich, Zurich |
Mulago Foundation | California, San Francisco, United States |
Polymatter | France, Ile-de-France, Paris |
Redesign Health | New York, New York, United States |
SHIFT I | - |
Space Capital | New York, New York, United States |
The Pearse Lyons Accelerator | County Dublin, Dublin, Ireland |
Wildcat Venture Partners | California, San Mateo, United States |
Zhe Chuang Tou | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
YUSUR Technology | 21 Dec 2021 | Beijing, Beijing, China | |||
Nutshell Therapeutics | $20M | 15 Jun 2021 | Huangpu, Shanghai, China | ||
Inmagene Biopharmaceuticals | $100M | 01 Jun 2021 | Zhangdian District, Shandong, China | ||
Dian Xiaomi | $23M | 18 Jan 2021 | Longgang District, Guangdong Province | ||
Nice Tuan | $196M | 30 Nov 2020 | China, Beijing | ||
Hengdache Shidai | $3M | 31 Mar 2016 | China, Beijing | ||
Nuode | $463K | 26 Feb 2016 | Jintan District, Jiangsu, China | ||
Zongheng Liuhe | $1M | 13 Aug 2013 | Qingyang District, Sichuan, China | ||
Zongheng Liuhe | $463K | 16 Sep 2012 | Qingyang District, Sichuan, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
YUSUR Technology | 21 Dec 2021 | Beijing, Beijing, China | |||
Nutshell Therapeutics | $20M | 15 Jun 2021 | Huangpu, Shanghai, China | ||
Inmagene Biopharmaceuticals | $100M | 01 Jun 2021 | Zhangdian District, Shandong, China | ||
Dian Xiaomi | $23M | 18 Jan 2021 | Longgang District, Guangdong Province | ||
Nice Tuan | $196M | 30 Nov 2020 | China, Beijing | ||
Hengdache Shidai | $3M | 31 Mar 2016 | China, Beijing | ||
Nuode | $463K | 26 Feb 2016 | Jintan District, Jiangsu, China | ||
Zongheng Liuhe | $1M | 13 Aug 2013 | Qingyang District, Sichuan, China | ||
Zongheng Liuhe | $463K | 16 Sep 2012 | Qingyang District, Sichuan, China |